2020年,亚洲占了全球头颈癌发病率的近65%。 虽然印度和中国贡献了大部分病例,但印度和澳大利亚的唇癌和口腔癌的发病率是所有病例中最高的。
Featured media on Novotech’s leadership and impact.
Expert insights and real-world perspectives.
In-depth perspectives on forces shaping clinical research.
Tracking science and trends across therapeutic areas.
Hear from experts shaping clinical development.
Conversations with leaders shaping drug development.
A global CRO and scientific partner advancing drug development.
Our impact extends beyond trials, shaping healthier futures worldwide.
A collaborative, science-driven approach.
Recognized for excellence across the industry.
Decades of clinical and scientific leadership.
A global clinical research leader with an award-winning culture.
A culture that empowers growth, innovation, and impact.
Explore career opportunities at Novotech.
Benefits and recognition that support your success.
Experts collaborating to advance clinical research.
A commitment to your growth and development.
Start your career in clinical research with Novotech.
2020年,亚洲占了全球头颈癌发病率的近65%。 虽然印度和中国贡献了大部分病例,但印度和澳大利亚的唇癌和口腔癌的发病率是所有病例中最高的。